IL160734A0 - Pharmaceutical composition comprising gamma-butyrobetaine - Google Patents

Pharmaceutical composition comprising gamma-butyrobetaine

Info

Publication number: IL160734A0
Authority: IL; Israel
Prior art keywords: butyrobetaine; gamma; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2001-09-07

Application number

IL16073402A

Other languages

English (en)

Inventor

Ivars Kalvinsh

Maris Veveris

Anatolijs Birmans

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-07

Filing date

2002-03-04

Publication date

2004-08-31

2002-03-04 Application filed filed Critical

2004-08-31 Publication of IL160734A0 publication Critical patent/IL160734A0/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Reproductive Health (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL16073402A 2001-09-07 2002-03-04 Pharmaceutical composition comprising gamma-butyrobetaine IL160734A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
LVP-01-134A LV12979B (en)	2001-09-07	2001-09-07	Pharmaceutical composition
PCT/LV2002/000004 WO2003022262A1 (en)	2001-09-07	2002-03-04	Pharmaceutical composition comprising gamma-butyrobetaine

Publications (1)

Publication Number	Publication Date
IL160734A0 true IL160734A0 (en)	2004-08-31

Family

ID=19735292

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16073402A IL160734A0 (en)	2001-09-07	2002-03-04	Pharmaceutical composition comprising gamma-butyrobetaine
IL160734A IL160734A (en)	2001-09-07	2004-03-04	Pharmaceutical preparation containing gamma-butyrobtaine and its use

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL160734A IL160734A (en)	2001-09-07	2004-03-04	Pharmaceutical preparation containing gamma-butyrobtaine and its use

Country Status (30)

Country	Link
US (1)	US20040242590A1 (xx)
EP (1)	EP1429753B1 (xx)
JP (1)	JP4382480B2 (xx)
KR (1)	KR100841035B1 (xx)
CN (1)	CN1275595C (xx)
AR (1)	AR036423A1 (xx)
AT (1)	ATE350029T1 (xx)
AU (1)	AU2002236340B2 (xx)
BG (1)	BG108673A (xx)
CA (1)	CA2459719C (xx)
CU (1)	CU23347B6 (xx)
DE (1)	DE60217369T2 (xx)
DK (1)	DK1429753T3 (xx)
EA (1)	EA006675B1 (xx)
ES (1)	ES2280505T3 (xx)
HK (1)	HK1068003A1 (xx)
HR (1)	HRPK20040328B3 (xx)
IL (2)	IL160734A0 (xx)
JO (1)	JO2507B1 (xx)
LV (1)	LV12979B (xx)
MA (1)	MA27683A1 (xx)
MX (1)	MXPA04002050A (xx)
MY (1)	MY134074A (xx)
NZ (1)	NZ532178A (xx)
PL (1)	PL368758A1 (xx)
PT (1)	PT1429753E (xx)
SI (1)	SI1429753T1 (xx)
TW (1)	TWI224506B (xx)
WO (1)	WO2003022262A1 (xx)
ZA (1)	ZA200402702B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10325813B4 (de)	2003-06-06	2007-12-20	Universitätsklinikum Freiburg	Prophylaxe und/oder Therapie bei der portalen Hypertonie
LV13450B (en) *	2004-08-24	2006-11-20	Grindeks As	Novel medicinal use of meldonium and pharmaceutical compositions thereof
EP1909576A4 (en)	2005-07-29	2010-09-01	Concert Pharmaceuticals Inc	NEW PHARMACEUTICAL COMPOUNDS
WO2009095445A1 (en) *	2008-01-29	2009-08-06	Grindeks	New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate
CN101781302B (zh) *	2009-05-31	2013-07-10	段波	一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用
RU2622757C1 (ru) *	2016-06-02	2017-06-19	федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет)	Способ лечения эректильной дисфункции

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1198434B (it) *	1981-01-06	1988-12-21	Sigma Tau Ind Farmaceuti	Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
LV11727B (en) *	1995-08-21	1997-08-20	Kalvins Ivars	Pharmaceutical composition
LV11728B (en) *	1995-08-21	1997-08-20	Kalvins Ivars	Pharmaceutical composition

2001
- 2001-09-07 LV LVP-01-134A patent/LV12979B/en unknown
2002
- 2002-03-04 IL IL16073402A patent/IL160734A0/xx unknown
- 2002-03-04 US US10/488,840 patent/US20040242590A1/en not_active Abandoned
- 2002-03-04 EA EA200400386A patent/EA006675B1/ru not_active IP Right Cessation
- 2002-03-04 ES ES02702955T patent/ES2280505T3/es not_active Expired - Lifetime
- 2002-03-04 WO PCT/LV2002/000004 patent/WO2003022262A1/en active IP Right Grant
- 2002-03-04 KR KR1020047003366A patent/KR100841035B1/ko not_active IP Right Cessation
- 2002-03-04 SI SI200230507T patent/SI1429753T1/sl unknown
- 2002-03-04 DK DK02702955T patent/DK1429753T3/da active
- 2002-03-04 CA CA2459719A patent/CA2459719C/en not_active Expired - Fee Related
- 2002-03-04 DE DE60217369T patent/DE60217369T2/de not_active Expired - Lifetime
- 2002-03-04 AT AT02702955T patent/ATE350029T1/de not_active IP Right Cessation
- 2002-03-04 MX MXPA04002050A patent/MXPA04002050A/es active IP Right Grant
- 2002-03-04 CN CNB028175077A patent/CN1275595C/zh not_active Expired - Fee Related
- 2002-03-04 PL PL02368758A patent/PL368758A1/xx unknown
- 2002-03-04 JP JP2003526391A patent/JP4382480B2/ja not_active Expired - Fee Related
- 2002-03-04 PT PT02702955T patent/PT1429753E/pt unknown
- 2002-03-04 AU AU2002236340A patent/AU2002236340B2/en not_active Ceased
- 2002-03-04 EP EP02702955A patent/EP1429753B1/en not_active Expired - Lifetime
- 2002-03-04 NZ NZ532178A patent/NZ532178A/en unknown
- 2002-08-29 MY MYPI20023224A patent/MY134074A/en unknown
- 2002-09-04 AR ARP020103331A patent/AR036423A1/es unknown
- 2002-09-05 TW TW091120239A patent/TWI224506B/zh not_active IP Right Cessation
- 2002-09-05 JO JO200291A patent/JO2507B1/en active
2004
- 2004-03-04 CU CU20040040A patent/CU23347B6/es unknown
- 2004-03-04 IL IL160734A patent/IL160734A/en not_active IP Right Cessation
- 2004-04-05 MA MA27608A patent/MA27683A1/fr unknown
- 2004-04-06 ZA ZA200402702A patent/ZA200402702B/en unknown
- 2004-04-07 BG BG108673A patent/BG108673A/xx unknown
- 2004-04-07 HR HR20040328A patent/HRPK20040328B3/xx not_active IP Right Cessation
2005
- 2005-01-11 HK HK05100218A patent/HK1068003A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
BG108673A (en)	2005-03-31
NZ532178A (en)	2007-05-31
AR036423A1 (es)	2004-09-08
JP2005504071A (ja)	2005-02-10
EA006675B1 (ru)	2006-02-24
EA200400386A1 (ru)	2004-08-26
CN1275595C (zh)	2006-09-20
CA2459719A1 (en)	2003-03-20
LV12979B (en)	2003-05-20
IL160734A (en)	2009-09-22
PL368758A1 (en)	2005-04-04
HK1068003A1 (en)	2005-04-22
CU23347B6 (es)	2009-02-20
ATE350029T1 (de)	2007-01-15
PT1429753E (pt)	2007-04-30
MY134074A (en)	2007-11-30
JO2507B1 (en)	2009-10-05
CA2459719C (en)	2010-07-06
KR20040034704A (ko)	2004-04-28
AU2002236340B2 (en)	2008-06-12
DE60217369T2 (de)	2007-08-23
ZA200402702B (en)	2005-05-11
JP4382480B2 (ja)	2009-12-16
WO2003022262A1 (en)	2003-03-20
KR100841035B1 (ko)	2008-06-24
MA27683A1 (fr)	2006-01-02
SI1429753T1 (sl)	2007-06-30
TWI224506B (en)	2004-12-01
CN1551764A (zh)	2004-12-01
HRP20040328A2 (en)	2004-08-31
EP1429753A1 (en)	2004-06-23
US20040242590A1 (en)	2004-12-02
ES2280505T3 (es)	2007-09-16
DK1429753T3 (da)	2007-05-14
EP1429753B1 (en)	2007-01-03
MXPA04002050A (es)	2004-06-07
DE60217369D1 (de)	2007-02-15
HRPK20040328B3 (en)	2006-02-28

Publication	Publication Date	Title
EP1450824A4 (en)	2005-09-28	PHARMACEUTICAL COMPOSITION
HK1072200A1 (en)	2005-08-19	Pro-micelle pharmaceutical compositions
GB0111597D0 (en)	2001-07-04	Pharmaceutical compositions
GB0319041D0 (en)	2003-09-17	Pharmaceutical Formulations
HUP0303163A3 (en)	2008-03-28	Tramadol-based pharmaceutical composition
GB0117057D0 (en)	2001-09-05	Pharmaceutical composition
HK1065257A1 (en)	2005-02-18	Medicinal composition
EP1408896A4 (en)	2010-02-24	PHARMACEUTICAL COMPOSITION
GB0129117D0 (en)	2002-01-23	Pharmaceutical composition
GB0121715D0 (en)	2001-10-31	Pharmaceutical formulations
GB0103638D0 (en)	2001-03-28	Pharmaceutical formulations
GB0120701D0 (en)	2001-10-17	Pharmaceutical formulations
GB2380129B (en)	2004-08-11	Pharmaceutical formulations
GB0105560D0 (en)	2001-04-25	Pharmaceutical formulations
GB0116107D0 (en)	2001-08-22	Pharmaceutical composition
HK1068277A1 (en)	2005-04-29	Pharmaceutical compositions comprising chelidonineor derivatives thereof
GB0127805D0 (en)	2002-01-09	Pharmaceutical composition
GB0104752D0 (en)	2001-04-18	Pharmaceutical compositions
PL370037A1 (en)	2005-05-16	Pharmaceutical composition
IL160734A0 (en)	2004-08-31	Pharmaceutical composition comprising gamma-butyrobetaine
GB2382302B (en)	2006-08-02	Pharmaceutical compositions
GB0114746D0 (en)	2001-08-08	Medicinal composition
IL157411A0 (en)	2004-03-28	Pharmaceutical composition
GB0124455D0 (en)	2001-12-05	Pharmaceutical formulations
GB0125061D0 (en)	2001-12-12	Pharmaceutical composition